![Rami Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rami Levin
Directeur Général chez
CNS PHARMACEUTICALS, INC.
Fortune : - $ au 31/07/2026
Profil
Rami Levin is President, Chief Executive Officer & Director at CNS Pharmaceuticals, Inc. since 2026.
Former positions include President & Chief Executive Officer at Saniona AB from 2020 to 2022, Chief Executive Officer at ImStem Biotechnology, Inc. from 2022 to 2024, Vice President-Marketing at EMD Serono, Inc., Head-North America at Swedish Orphan Biovitrum AB, and President at Swedish Orphan Biovitrum, Inc. Education includes undergraduate studies at Tel-Aviv University and an MBA from Recanati Business School Tel Aviv University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Rami Levin
| Sociétés | Poste | Début |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Directeur Général | 01/01/2026 |
Anciens postes connus de Rami Levin
| Sociétés | Poste | Fin |
|---|---|---|
ImStem Biotechnology, Inc.
 ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology Provides therapeutic and research products | Directeur Général | 01/01/2024 |
| SANA AB | Directeur Général | 30/04/2022 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | President | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Sales & Marketing | - |
Formation de Rami Levin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
ImStem Biotechnology, Inc.
ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology Provides therapeutic and research products | Health Technology |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Recanati Business School Tel Aviv University
 Recanati Business School Tel Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
